(Q34212230)

31 July 2017

1 reference

title

Diabetes prevalence and risk factors in polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

31 July 2017

main subject

1 reference

1 reference

Legro RS

1

1 reference

31 July 2017

language of work or name

1 reference

1 March 2001

1 reference

Obstetrics and Gynecology Clinics of North America

31 July 2017

published in

1 reference

31 July 2017

volume

28

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

99-109

1 reference

Impact of family history of diabetes on the assessment of beta-cell function.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Insulin sensitivity is not impaired in Mexican-American women without a family history of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Weight as a risk factor for clinical diabetes in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Hyperinsulinemia in the polycystic ovary syndrome: a clinical, endocrine and echographic study in 240 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Lack of predictive value of HbA1 for impaired glucose tolerance in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Exercise, glucose transport, and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Defects in beta-cell function in functional ovarian hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

A two-step model for development of non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

The natural history of impaired glucose tolerance in the Pima Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Effects of metformin in obese patients with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Features of syndrome X in first-degree relatives of NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

Obesity, lipids, cardiovascular risk, and androgen excess

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970188-1

7 January 2021

10.1016/S0889-8545(05)70188-1

Identifiers

DOI

1 reference

31 July 2017

1 reference